GLP-1 initiation was driven primarily by nurse practitioners (28.0%), family medicine providers (22.4%), endocrinologists (16.3%), internal medicine providers (11.1%), and physician assistants (10.3%), while OB/GYN providers accounted for 5.5%
A reconstituted BPC 157 solution should be clear and colorless
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have gained considerable attention in recent years as promising therapeutic agents for MASLD, particularly owing to their well-established efficacy in treating type 2 diabetes mellitus (T2DM) and obesity, conditions closely implicated to MASLD pathogenesis (2, 5)
2024 mdecine/sciences Inserm Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform
Switching from semaglutide to retatrutide may be appropriate in some situations, but it should only be done under medical supervision
Some patients may experience mild injection site reactions, but these are typically temporary
